Rubius Therapeutics, Inc.

CIK 1709401 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Rubius Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 10, 2023SC 13G/A0000315066-23-002230
Apr 10, 202315-12G0001104659-23-043593
Apr 6, 20238-K0001104659-23-042792
Mar 28, 2023250001104659-23-037737
Mar 9, 2023DEF 14A0001104659-23-030329
Mar 3, 2023SC 13G/A0001088875-23-000072
Mar 3, 20238-K0001104659-23-028428
Mar 2, 2023PRER14A0001104659-23-027696
Feb 27, 202310-K0001709401-23-000005
Feb 27, 2023PRE 14A0001104659-23-025672
Feb 27, 2023S-8 POS0001104659-23-025604
Feb 27, 2023S-8 POS0001104659-23-025606
Feb 27, 2023S-8 POS0001104659-23-025602
Feb 27, 2023S-8 POS0001104659-23-025605
Feb 27, 202340001104659-23-026139
Feb 27, 2023S-8 POS0001104659-23-025607
Feb 22, 2023RW0001104659-23-024021
Feb 22, 20238-K0001104659-23-024013
Feb 14, 2023SC 13G/A0001193125-23-038310
Feb 9, 2023SC 13G/A0000315066-23-002039
Feb 6, 20238-K0001104659-23-011161
Feb 1, 202340001104659-23-009464
Feb 1, 202340001104659-23-009465
Jan 31, 202340001104659-23-008874
Jan 31, 202340001104659-23-008873